Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass
Case Reports in Nephrology and Dialysis · 20.09.2016 · 6 (3) · 114-119
DOI: 10.1159/000449128 ↗Kurz gefasst
Fallbericht in der Zeitschrift Case Reports in Nephrology and Dialysis, online erschienen am 20.09.2016. Verfasst von Varun Agrawal und 3 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology and Hypertension, University of Vermont, Burlington, Vt., USA. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Hyperoxaluria after Roux-en-Y gastric bypass (RYGB) increases the risk for kidney injury. Medical therapies for hyperoxaluria have limited efficacy. A 65-year-old female was evaluated for acute kidney injury [AKI, serum creatinine (Cr) 2.1 mg/dl, baseline Cr 1.0 mg/dl]. She did not have any urinary or gastrointestinal symptoms or exposure to nephrotoxic agents. Sixteen months prior to this evaluation, she underwent RYGB for morbid obesity. Her examination was unremarkable for hypertension or edema and there was no protein or blood on urine dipstick. Kidney biopsy revealed acute tubulointerstitial nephritis with oxalate crystals in tubules. The concurrent finding of severe hyperoxaluria (urine oxalate 150 mg/day) confirmed the diagnosis of oxalate nephropathy. Despite medical management of hyperoxaluria, her AKI worsened. Laparoscopic reversal of RYGB was performed and within 1 month, her hyperoxaluria resolved (urine oxalate 20 mg/day) and AKI improved (Cr 1.7 mg/dl). Surgical reversal of RYGB may be considered in patients with oxalate nephropathy at high risk of progression who fail medical therapy. Physicians need to be aware of the possibility of oxalate nephropathy after RYGB and promptly treat the hyperoxaluria to halt further kidney damage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Nephrology and Hypertension, University of Vermont, Burlington, Vt., USA.
- Department of Medicine, University of Vermont, Burlington, Vt., USA.
- Bozeman Health Nephrology, Bozeman, Mont., USA.
- Department of Pathology and Laboratory Medicine, University of Vermont, Burlington, Vt., USA.
Zitieren
APA
Agrawal, V., Wilfong, J. B., Rich, C. E., & Gibson, P. C. (2016). Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass. Case Reports in Nephrology and Dialysis, 6(3), 114-119. https://doi.org/10.1159/000449128
Vancouver
Agrawal V, Wilfong JB, Rich CE, Gibson PC. Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass. Case Reports in Nephrology and Dialysis. 2016;6(3):114-119. doi:10.1159/000449128
BibTeX
@article{Agrawal2016,
author = {Agrawal, Varun and Wilfong, Jonathan B and Rich, Christopher E and Gibson, Pamela C},
title = {Reversal of Gastric Bypass Resolves Hyperoxaluria and Improves Oxalate Nephropathy Secondary to Roux-en-Y Gastric Bypass},
journal = {Case Reports in Nephrology and Dialysis},
year = {2016},
volume = {6},
number = {3},
pages = {114--119},
doi = {10.1159/000449128}
}
EUVIMED